Press Releases
![](assets/images/b/ProBioGen_Cell_Line_AGE1.CR.PIX_Kryolager2_resized-001d2523.jpg)
ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
read more ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
read more ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
![](assets/images/7/Thermo_Fisher_FreedomKit_ExpiCHO-S_mid-3611e8bf.jpg)
ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
read more ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
![](assets/images/1/VSA_Symposium2-12dfdc0a.jpeg)
ProBioGen Celebrates "A New Dawn in Biotechnology"
read more ProBioGen Celebrates "A New Dawn in Biotechnology"
![](assets/images/e/20220913_LHI_DIND_Awards1-50323e3f.jpg)
ProBioGen Receives Employer of the Future and Top Service Awards
read more ProBioGen Receives Employer of the Future and Top Service Awards
![](assets/images/c/AGE1.CR.pIX1107-8f471338.jpg)
ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine
![](assets/images/a/Intelligent_Biopharmaceutical_Solutions-53833c7b.jpeg)
ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing
ValenzaBio Engages ProBioGen For a Second Service Project
read more ValenzaBio Engages ProBioGen For a Second Service Project